The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.00%)
Open: 20.50
High: 20.50
Low: 20.50
Prev. Close: 20.50
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with Smiths Medical

1 Dec 2006 12:23

Inditherm PLC01 December 2006 Press Release 1 December 2006 Inditherm plc ("Inditherm" or "The Company") US Distributorship Agreement with Smiths Medical Critical Care Inditherm plc (AIM: IDM), the provider of innovative heating solutions to thefood, industrial process, utility, medical, construction and sport industries,has signed an exclusive distribution agreement with Smiths Medical CriticalCare, (a Division of Smiths Medical), to distribute Inditherm's patient warmingproducts in the USA. Smiths Medical is a division of Smiths Group plc (FTSE:SMIN.L). Under this agreement, which has a term of at least 3 years, Smiths Medical willsell Inditherm heated mattresses and blankets under their Level 1(R) brand nameto the US medical market. The Inditherm products complement Smiths Medicals'existing range and can be used in a variety of areas, including operating rooms,pre- and post- operative areas and intensive care units. Inditherm's patient warming products are based upon The Company's unique,patented, low voltage conductive polymer technology, which provides uniform,direct heating, resulting in much better thermal transfer performance andadvantages over traditional patient warming methods. Smiths Medical has a well-established market presence in the US patient warmingsector with a large sales team, directed at hospitals throughout the US. Underthe terms of the agreement, sales are targeted to reach up to US$5million in thethird year. Smiths Medical Critical Care has undertaken to place an immediate order forheating mattresses worth at least $275,000 for demonstration stock. These willbe used for sales training early in the New Year and for demonstrations to andevaluations by potential customers. Commenting on the agreement, Inditherm's CEO, Richard Harpum said: "This is amajor step forward for Inditherm and a solid endorsement of our patient warmingtechnology by a world leader in medical products. Smiths Medical makes anexcellent partner, as they have the capability to accelerate our entry into theUS market". As stated in the Company's interim results on 28th September this year, therehas been encouraging progress made across all of the Company's core businessareas, although additional funds are required to continue the development. TheBoard is pursuing various strategic options to secure such funding. - Ends - For further information contact: Inditherm plcRichard Harpum, CEO +44 (0) 1709 761000rharpum@indithermplc.com www.inditherm.comIan Smith, Finance Director +44 (0) 1709 761000ismith@indithermplc.comAbchurchJustin Heath +44 (0) 113 203 1340justin.heath@abchurch-group.com www.abchurch-group.com Editors' Notes Inditherm plc Inditherm plc is an AIM-listed provider of low voltage, cost-effective heatingtechnology. It manufactures, installs and licenses its specialised, patentedheating technology for use in numerous applications that require temperaturemaintenance or frost protection, including industrial, utility, medical,construction, and sports turf heating. The Rotherham-based company operates ina global environment and has a blue-chip customer base. Inditherm's technology uses a carbon-based, electrically conductive polymer,also called Inditherm, to produce a cost-effective, flexible and adaptableheating surface. Powered by a low voltage supply, Inditherm generates uniformheat over its entire surface with no hot spots. Inditherm received US Food & Drug Administration clearance for its patientwarming products In May 2006. Smiths Medical Smiths Medical, a division of Smiths Group plc (LSE: SMIN.L) is aclinically-focused global leader in the design, manufacture, and distribution ofmedical devices used for a variety of therapeutic, diagnostic, and surgicalprocedures. The company's portfolio includes airway management, pain management,temperature management systems, infusion systems, implantable access systems,safety I.V. catheters, critical care monitoring, and insulin delivery systems.This product range offers customers clinical and economical advantages backed byexperience, innovation, and value-added services, including extensive producttraining and support. For more information, please visit http://www.smiths-medical.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Sep 201910:09 amRNSDirector/PDMR Shareholding
23rd Sep 20193:42 pmRNSResult of General Meeting
12th Sep 20197:00 amRNSNotice of Interim Results
5th Sep 20197:00 amRNSProposed Acquisition of Vio Holdings and Placing
15th Aug 20197:00 amRNSTrading Update
27th Jun 20191:16 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement
28th May 20197:00 amRNSUpdate regarding NPXe plc
23rd May 20197:00 amRNSNotice of AGM
30th Apr 20197:00 amRNSPreliminary Results
23rd Apr 20197:00 amRNSWinning of Queen's Award for Enterprise
20th Mar 20197:00 amRNSCertification received to the new MDSAP
14th Mar 20197:00 amRNSLargest Ever Patient Warming System Order
22nd Feb 20197:00 amRNSTrading Update and Notice of Results
11th Feb 201911:01 amRNSPrice Monitoring Extension
25th Jan 20197:00 amRNSGrowth & Innovation Forum 2019
18th Dec 20187:00 amRNSLicensing agreement with US University
7th Dec 20187:00 amRNSStatement re potential IPO of NeuroproteXeon
8th Nov 20187:00 amRNSGrant of Options
2nd Oct 20187:00 amRNSInterim Results
30th Aug 20187:00 amRNSInvestor Evening - 4 October 2018
24th Aug 20187:00 amRNSTrading Update and Notice of Results
3rd Jul 20187:00 amRNSRenewal of Tecotherm and Micrel Agreements
15th Jun 201812:30 pmRNSResult of AGM
15th Jun 20187:00 amRNSAGM Statement
7th Jun 20187:00 amRNSPotential IPO of NeuroproteXeon Limited
18th May 201811:59 amRNSPosting of Annual Report and Notice of AGM
9th May 20183:15 pmRNSNeuroproteXeon and Linde Distribution Partnership
24th Apr 20187:00 amRNSPreliminary Results
21st Feb 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSCFM unit granted CE mark and Neotech Agreement.
9th Jan 20187:00 amRNSAppointment of Head of Marketing
14th Nov 20177:00 amRNSEnhanced LifeStart launched at MEDICA
9th Nov 20177:00 amRNSGrant of Options
17th Oct 20179:15 amRNSCorrected rPAP Driver Unit Granted CE mark notice
17th Oct 20177:00 amRNSNeonatal Resuscitation Driver Granted CE mark
3rd Oct 20177:00 amRNSNeuroproteXeon and Mallinckrodt licence agreement
26th Sep 20177:00 amRNSInterim Results
11th Sep 20177:00 amRNSTR1 Notification of Major Interest in Shares
31st Aug 20177:00 amRNSOperational Appointments
25th Aug 20177:00 amRNSTrading Update and Notice of Results
17th Aug 20177:00 amRNSCapital Reduction
14th Aug 20177:00 amRNSInvestors Open Day
31st Jul 20172:45 pmRNSCapital Reduction
30th Jun 201712:01 pmRNSResult of AGM
30th Jun 20177:00 amRNSAGM Statement
19th May 20177:00 amRNSPosting of Annual Report and Notice of AGM
3rd May 20177:00 amRNSPreliminary Results
4th Apr 20174:25 pmRNSNotice of Results
4th Apr 20172:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.